Signet Closes Third Fund At $129M

Signet Healthcare Partnershas closed its third investment fund at about $129 million,Private Equity Hubreports. The closing of the new portfolio brings the New York-based firm’s total funds under management to $328 million.

The fund will primarily be invested in companies producing generic and specialty pharmaceuticals, biopharmaceuticals, medical devices and other related technology, diagnostics, and research-based companies supporting the industry. The portfolio is expected to invest over a four-year period with individual investments in the $6-15 million range.

Click here for the story fromPrivate Equity Hub.